Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Nat Commun ; 4: 1484, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23403561

RESUMEN

Brain cells are immersed in a complex structure forming the extracellular matrix. The composition of the matrix gradually matures during postnatal development, as the brain circuitry reaches its adult form. The fully developed extracellular environment stabilizes neuronal connectivity and decreases cortical plasticity as highlighted by the demonstration that treatments degrading the matrix are able to restore synaptic plasticity in the adult brain. The mechanisms through which the matrix inhibits cortical plasticity are not fully clarified. Here we show that a prominent component of the matrix, chondroitin sulfate proteoglycans (CSPGs), restrains morphological changes of dendritic spines in the visual cortex of adult mice. By means of in vivo and in vitro two-photon imaging and electrophysiology, we find that after enzymatic digestion of CSPGs, cortical spines become more motile and express a larger degree of structural and functional plasticity.


Asunto(s)
Envejecimiento/fisiología , Espinas Dendríticas/fisiología , Matriz Extracelular/metabolismo , Plasticidad Neuronal/fisiología , Corteza Visual/crecimiento & desarrollo , Corteza Visual/fisiología , Animales , Condroitina ABC Liasa/farmacología , Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Espinas Dendríticas/efectos de los fármacos , Electrodos , Potenciales Evocados Visuales/efectos de los fármacos , Matriz Extracelular/efectos de los fármacos , Fluorescencia , Proteínas Fluorescentes Verdes/metabolismo , Potenciación a Largo Plazo/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Movimiento/efectos de los fármacos , Plasticidad Neuronal/efectos de los fármacos , Corteza Visual/efectos de los fármacos
2.
Conf Proc IEEE Eng Med Biol Soc ; 2004: 3485-8, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-17271037

RESUMEN

Managing medical equipments is a formidable task that has to be pursued maximizing the benefits within a highly regulated and cost-constrained environment. Clinical engineers are uniquely equipped to determine which policies are the most efficacious and cost effective for a health care institution to ensure that medical devices meet appropriate standards of safety, quality and performance. Part of this support is a strategy for preventive and corrective maintenance. This paper describes an alternative scheme of OEM (Original Equipment Manufacturer) service contract for medical equipment that combines manufacturers' technical support and in-house maintenance. An efficient and efficacious organization can reduce the high cost of medical equipment maintenance while raising reliability and quality. Methodology and results are discussed.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...